On the public citation graph

Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection

https://doi.org/10.1681/asn.2021020188
0 signed · 25 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.jim.2021.113046openalex-snapshot
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients
inferredcites →https://doi.org/10.1056/nejmoa2034545openalex-snapshot
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
inferredcites →https://doi.org/10.1126/science.abd7728openalex-snapshot
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
inferredcites →https://doi.org/10.1126/science.abf4063openalex-snapshot
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
inferredcites →https://doi.org/10.1371/journal.pone.0241263openalex-snapshot
Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis
inferredcites →https://doi.org/10.2215/cjn.00950208openalex-snapshot
Aspects of Immune Dysfunction in End-stage Renal Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4103025openalex-extracted
SARS-CoV-2 Seroprevalence in Malawian Breastfed Infants between February 2020 And May 2021
inferred← citeshttps://doi.org/10.1007/s13730-022-00697-zopenalex-snapshot
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/b978-0-443-19170-1.00045-0openalex-snapshot
Clinical implications of COVID-19 in chronic kidney disease and end-stage kidney disease
inferred← citeshttps://doi.org/10.1016/j.jcvp.2022.100110openalex-snapshot
Dynamics of SARS-CoV-2 exposure in Malawian infants between February 2020 and May 2021
inferred← citeshttps://doi.org/10.1016/j.kint.2021.10.006openalex-snapshot
Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost
inferred← citeshttps://doi.org/10.1016/j.kint.2022.01.022openalex-snapshot
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126544openalex-snapshot
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients
inferred← citeshttps://doi.org/10.1093/ckj/sfac174openalex-snapshot
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
inferred← citeshttps://doi.org/10.1101/2021.12.30.21268308openalex-snapshot
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose
inferred← citeshttps://doi.org/10.1101/2024.01.14.575569openalex-snapshot
Different vaccine platforms result in distinct antibody responses to the same antigen in haemodialysis patients
inferred← citeshttps://doi.org/10.1111/1744-9987.13735openalex-snapshot
Lethal Covid‐19 in two vaccinated hemodialysis patients
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-062187openalex-snapshot
Cohort profile:Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
inferred← citeshttps://doi.org/10.2215/cjn.11820921openalex-snapshot
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1376654openalex-snapshot
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
inferred← citeshttps://doi.org/10.3389/fmed.2021.796676openalex-snapshot
Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up
inferred← citeshttps://doi.org/10.3390/vaccines12121312openalex-snapshot
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic
inferred← citeshttps://doi.org/10.3390/vaccines13010007openalex-snapshot
Distinct Neutralising and Complement-Fixing Antibody Responses Can Be Induced to the Same Antigen in Haemodialysis Patients After Immunisation with Different Vaccine Platforms
inferred← citeshttps://doi.org/10.3390/vaccines13090965openalex-snapshot
Antibody Responses to SARS-CoV-2 and Common HCoVs in Hemodialysis Patients and Transplant Recipients: Data from the Dominican Republic
inferred← citeshttps://doi.org/10.34067/kid.0000000000000490openalex-snapshot
Long-Term Morbidity and Mortality of Coronavirus Disease 2019 in Patients Receiving Maintenance Dialysis: A Multicenter Population-Based Cohort Study
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.